Mereo BioPharma (MREO) Prepaid Assets (2017 - 2026)

Mereo BioPharma (MREO) has reported Prepaid Assets for 10 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.

• Quarterly Prepaid Assets fell 10.72% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (down 10.72% YoY) and the FY2025 annual result came in at $2.5 million, up 16.37% from the prior year.
• Prepaid Assets retreated to $2.2 million in Q1 2026 per MREO's latest filing, from $2.5 million in the prior quarter.
• Over the last five years, Prepaid Assets for MREO reached as high as $5.2 million in Q4 2023 and fell as low as $1.7 million in Q2 2023.
• A 5-year average of $3.1 million and a median of $2.7 million in 2025 frame the typical range for Prepaid Assets.
• The largest YoY upside for Prepaid Assets was 160.7% in 2024 against a maximum downside of 57.82% in 2024.
• Year by year, Prepaid Assets stood at $3.7 million in 2022, then jumped by 40.67% to $5.2 million in 2023, then tumbled by 57.82% to $2.2 million in 2024, then grew by 16.37% to $2.5 million in 2025, then retreated by 11.14% to $2.2 million in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $2.2 million, $2.5 million, and $2.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.